Electroacupuncture for tapering off long-term benzodiazepine use: study protocol of randomized controlled trial

Wing-Fai Yeung, Ka-Fai Chung, Zhang-Jin Zhang, Wai-Chi Chan, Shi-Ping Zhang, Roger Man-Kin Ng, Connie Lai-Wah Chan, Lai-Ming Ho, Yee-Man Yu, Li-Xing Lao, Wing-Fai Yeung, Ka-Fai Chung, Zhang-Jin Zhang, Wai-Chi Chan, Shi-Ping Zhang, Roger Man-Kin Ng, Connie Lai-Wah Chan, Lai-Ming Ho, Yee-Man Yu, Li-Xing Lao

Abstract

Background: Conventional approaches for benzodiazepine tapering have their limitations. Anecdotal studies have shown that acupuncture is a potential treatment for facilitating successful benzodiazepine tapering. As of today, there was no randomized controlled trial examining its efficacy and safety. The purpose of the study is to evaluate the efficacy of using electroacupuncture as an adjunct treatment to gradual tapering of benzodiazepine doses in complete benzodiazepine cessation in long-term benzodiazepine users.

Methods/design: The study protocol of a randomized, assessor- and subject-blinded, controlled trial is presented. One hundred and forty-four patients with histories of using benzodiazepines in ≥50% of days for more than 3 months will be randomly assigned in a 1:1 ratio to receive either electroacupuncture or placebo electroacupuncture combined with gradual benzodiazepine tapering schedule. Both experimental and placebo treatments will be delivered twice per week for 4 weeks. Major assessments will be conducted at baseline, week 6 and week 16 post-randomization. Primary outcome is the cessation rate of benzodiazepine use. Secondary outcomes include the percentage change in the doses of benzodiazepine usage and the severity of withdrawal symptoms experienced based on the Benzodiazepine Withdrawal Symptom Questionnaire, insomnia as measured by the Insomnia Severity Index, and anxiety and depressive symptoms as evaluated by the Hospital Anxiety and Depression Scale. Adverse events will also be measured at each study visit.

Discussion: Results of this study will provide high quality evidence of the efficacy and safety of electroacupuncture as an adjunct treatment for benzodiazepine tapering in long-term users.

Trial registration: ClinicalTrials.gov NCT02475538 .

Keywords: Acupuncture; Benzodiazepine discontinuation; RCT; Sham; Withdrawal.

Figures

Fig. 1
Fig. 1
Flowchart of study procedures
Fig. 2
Fig. 2
Benzodiazepine gradual tapering schedule

References

    1. Holden JD, Hughes IM, Tree A. Benzodiazepine prescribing and withdrawal for 3234 patients in 15 general practices. Fam Pract. 1994;11:358–362. doi: 10.1093/fampra/11.4.358.
    1. Australian Bureau of Statistics . National Health Survey, first results, Australia, 1995. Canberra: Australian Bureau of Statistics; 1996.
    1. Petitjean S, Ladewig D, Meier CR, Amrein R, Wiesbeck GA. Benzodiazepine prescribing to the Swiss adult population: results from a national survey of community pharmacies. Int Clin Psychopharmacol. 2007;22:292–298. doi: 10.1097/YIC.0b013e328105e0f2.
    1. Kan CC, Breteler MH, Zitman FG. High prevalence of benzodiazepine dependence in out-patient users, based on the DSM-III-R and ICD-10 criteria. Acta Psychiatr Scand. 1997;96:85–93. doi: 10.1111/j.1600-0447.1997.tb09911.x.
    1. Lader M, Tylee A, Donoghue J. Withdrawing benzodiazepines in primary care. CNS Drugs. 2009;23:19–34. doi: 10.2165/0023210-200923010-00002.
    1. Verwey B, Eling P, Wientjes H, Zitman FG. Memory impairment in those who attempted suicide by benzodiazepine overdose. J Clin Psychiatry. 2000;61:456–459. doi: 10.4088/JCP.v61n0612.
    1. Chung KF, Cheung RC, Tam JW. Long-term benzodiazepine users-characteristics, views and effectiveness of benzodiazepine reduction information leaflet. Singap Med J. 1999;40:138–143.
    1. Schweizer E, Rickels K. Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatr Scand Suppl. 1998;393:95–101. doi: 10.1111/j.1600-0447.1998.tb05973.x.
    1. Rickels K, Case WG, Downing RW, Winokur A. Long-term diazepam therapy and clinical outcome. JAMA. 1983;250:767–771. doi: 10.1001/jama.1983.03340060045024.
    1. Pecknold JC. Discontinuation reactions to alprazolam in panic disorder. J Psychiatr Res. 1993;27:155–170. doi: 10.1016/0022-3956(93)90025-W.
    1. Parr JM, Kavanagh DJ, Cahill L, Mitchell G, McD YR. Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. Addiction. 2009;104:13–24. doi: 10.1111/j.1360-0443.2008.02364.x.
    1. Gould RL, Coulson MC, Patel N, Highton-Williamson E, Howard RJ. Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials. Br J Psychiatry. 2014;204:98–107. doi: 10.1192/bjp.bp.113.126003.
    1. Krystal AD. The changing perspective on chronic insomnia management. J Clin Psychiatry. 2004;65:20–25.
    1. Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract. 2012;66:924–939. doi: 10.1111/j.1742-1241.2012.02945.x.
    1. Kaptchuk TJ. Acupuncture: theory, efficacy, and practice. Ann Intern Med. 2002;136:374–383. doi: 10.7326/0003-4819-136-5-200203050-00010.
    1. Pilkington K, Kirkwood G, Rampes H, Cummings M, Richardson J. Acupuncture for anxiety and anxiety disorders--a systematic literature review. Acupunct Med. 2007;25:1–10. doi: 10.1136/aim.25.1-2.1.
    1. Yeung WF, Chung KF, Leung YK, Zhang SP, Law AC. Traditional needle acupuncture treatment for insomnia: a systematic review of randomized controlled trials. Sleep Med. 2009;10:694–704. doi: 10.1016/j.sleep.2008.08.012.
    1. Cheuk DK, Yeung WF, Chung KF, Wong V. Acupuncture for insomnia. Cochrane Database Syst Rev. 2012;9:CD005472.
    1. Ruan JW, Zheng PY. Therapeutic analysis on the acupuncture for drug-dependence insomnia. Chin J Rehab Med. 2002;17:167–168.
    1. Zhang Y, Liu SW, Hou YC. Acupuncture treatment of drug-dependence insomnia. Chin Acupunct Moxibust. 2001;22:85.
    1. Qiao YY. Thirty cases of anxiety symptom treated with Shenmen-through-Shaohai point. Chin Acupunct Moxibust. 2002;21:81–82.
    1. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG, Consort CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012;10:28–55. doi: 10.1016/j.ijsu.2011.10.001.
    1. MacPherson H, Altman DG, Hammerschlag R, Li Y, Wu T, White A, Moher D, Group SR Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. Acupunct Med. 2010;28:83–93. doi: 10.1136/aim.2009.001370.
    1. World Health Organisation Collaborating Centre for Drug Statistics Methodology . Guidelines for ATC Classification and DDD Assignment. 5. Oslo, Norway: World Health Organisation; 2002.
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62. doi: 10.1136/jnnp.23.1.56.
    1. Chung KF, Yeung WF, Yu YM, Yung KP, Zhang SP, Zhang ZJ, Wong MT, Lee WK, Chan LW. Acupuncture for residual insomnia associated with major depressive disorder: A placebo- and sham-controlled, subject- and assessor-blind, randomized trial. J Clin Psychiatry. 2015;76:e752–e760. doi: 10.4088/JCP.14m09124.
    1. Yeung WF, Chung KF, Poon MM, Ho FY, Zhang SP, Zhang ZJ, Ziea ET, Wong TV. Prescription of chinese herbal medicine and selection of acupoints in pattern-based traditional chinese medicine treatment for insomnia: a systematic review. Evid Based Complement Alternat Med. 2012;2012:902578. doi: 10.1155/2012/902578.
    1. Yeung WF, Chung KF, Tso KC, Zhang SP, Zhang ZJ, Ho LM. Electroacupuncture for residual insomnia associated with major depressive disorder: a randomized controlled trial. Sleep. 2011;34:807–815.
    1. Rickels K, Schweizer E, Case WG, Greenblatt DJ. Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. Arch Gen Psychiatry. 1990;47:899–907. doi: 10.1001/archpsyc.1990.01810220015002.
    1. Zitman FG, Couvée JE. Chronic benzodiazepine use in general practice patients with depression: an evaluation of controlled treatment and taper-off: report on behalf of the Dutch Chronic Benzodiazepine Working Group. Br J Psychiatry. 2001;178:317–324. doi: 10.1192/bjp.178.4.317.
    1. Tyrer P, Murphy S, Riley P. The benzodiazepine withdrawal symptom questionnaire. J Affect Disord. 1990;19:53–61. doi: 10.1016/0165-0327(90)90009-W.
    1. Streitberger K, Kleinhenz J. Introducing a placebo needle into acupuncture research. Lancet. 1998;352:364–365. doi: 10.1016/S0140-6736(97)10471-8.
    1. Morin CM, Bastien C, Guay B, Radouco-Thomas M, Leblanc J, Vallières A. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry. 2004;161:332–342. doi: 10.1176/appi.ajp.161.2.332.
    1. Voshaar RC, Gorgels WJMJ, Mol AJJ, Van Balkom AJLM, Van de Lisdonk EH, Breteler MHM, van den Hoogen HJ, Zitman FG. Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three conditioned, randomised controlled trial. Br J Psychiatry. 2003;182:498–504. doi: 10.1192/bjp.182.6.498.
    1. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2:297–307. doi: 10.1016/S1389-9457(00)00065-4.
    1. Chung KF, Kan KK, Yeung WF. Assessing insomnia in adolescents: comparison of Insomnia Severity Index, Athens Insomnia Scale and Sleep Quality Index. Sleep Med. 2011;12:463–470. doi: 10.1016/j.sleep.2010.09.019.
    1. Leung CM, Wing YK, Kwong PK, Lo A, Shum K. Validation of the Chinese-Cantonese version of the hospital anxiety and depression scale and comparison with the Hamilton Rating Scale of Depression. Acta Psychiatr Scand. 1999;100:456–461. doi: 10.1111/j.1600-0447.1999.tb10897.x.
    1. Vincent C. Credibility assessment in trials of acupuncture. Complement Med Res. 1990;4:8–11.
    1. Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995;90:607–614. doi: 10.1111/j.1360-0443.1995.tb02199.x.
    1. Chen VC, Chen H, Lin TY, Chou HH, Lai TJ, Ferri CP, Gossop M. Severity of heroin dependence in Taiwan: Reliability and validity of the Chinese version of the Severity of Dependence Scale (SDS[Ch]) Addict Behav. 2008;33:1590–1593. doi: 10.1016/j.addbeh.2008.06.001.
    1. Chung KF, Yeung WF, Kwok CW, Yu YM. Risk factors associated with adverse events of acupuncture: a prospective study. Acupunct Med. 2014;32:455–462. doi: 10.1136/acupmed-2014-010635.
    1. Chung KF, Yeung WF, Yu YM, Kwok CW, Zhang SP, Zhang ZJ. Adverse Events Related to Acupuncture: Development and Testing of a Rating Scale. Clin J Pain. 2015;31:922–928. doi: 10.1097/AJP.0000000000000189.
    1. Park J, White AR, James MA, Hemsley AG, Hohnson P, Chambers J, Ernst E. Acupuncture for subacute stroke rehabilitation. A sham-controlled, subject- and assessor-blind, randomized trial. Arch Intern Med. 2005;165:2026–2031. doi: 10.1001/archinte.165.17.2026.
    1. Portney LG, Watkins MP. Foundations of clinical research: applications to practice. 3. Upper Saddle River, N.J: Pearson/Prentice Hall; 2009.
    1. Little RJA, Rubin DB. Statistical Analysis with Missing Data. 2. Hoboken, NJ: Wiley; 2002.
    1. Little RJA. Pattern-Mixture Models for Multivariate Incomplete Data. J Am Stat Assoc. 1993;88:125–134.
    1. rctmiss – analyse a RCT allowing for informatively missing outcome data. . Accessed 27 Mar 2017.
    1. Chung KF. Benzodiazepine prescribing trend after its inclusion as a dangerous drug under the Hong Kong Dangerous Drugs Ordinance. Hong Kong Med J. 1997;3:16–20.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit